DNA SEQ leverages AI and crystallography to provide genomic profiling services that match cancer patients' genomic profiles with targeted therapies. Utilizing a unique crystallography-based filtering methodology and a proprietary crystal structures library, DNA SEQ's machine learning algorithm offers predictive personalized medicine. This approach aids physicians in making informed treatment decisions for oncology patients, enhancing the precision of targeted cancer therapies.
DNA SEQ has developed a significant technological alliance, integrating structural genomics with advanced machine learning. Their innovative methodology has positioned them as a key player in the field of personalized oncology treatment. By focusing on matching specific genomic profiles with available targeted drugs, DNA SEQ has made substantial strides in improving patient outcomes and advancing the field of precision medicine.
